Oncolytics Biotech Inc. Research Collaborators To Present Reovirus Data At American Association for Cancer Research Conference

CALGARY, April 4 /CNW/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced that a poster by Dr. E. Anders Kolb of the Albert Einstein College of Medicine, Bronx, New York, entitled "Reolysin(R), an unmodified Reovirus, has significant anti-tumor activity in childhood sarcomas" will be presented today at the 97th American Association for Cancer Research (AACR) Annual Meeting in Washington, D.C. The research abstract and poster are available on the Oncolytics website.